UniQure Publishes Phase I/II Trial Results of AMT-060 Gene Therapy in Treating Hemophilia B
geralt / Pixabay

UniQure Publishes Phase I/II Trial Results of AMT-060 Gene Therapy in Treating Hemophilia B

Pharmaceutical company and gene therapy leader, uniQure, published promising data from their current phase I/II trial testing out a gene therapy called AMT-060 in patients with serious cases of hemophilia B.…

Continue Reading UniQure Publishes Phase I/II Trial Results of AMT-060 Gene Therapy in Treating Hemophilia B
Do You Think This Is Illegal Discrimination Against Hemophilia Patients?
pixabay.com

Do You Think This Is Illegal Discrimination Against Hemophilia Patients?

Did Wellmark Blue Cross and Blue Shield cross the line? Leading hemophilia groups, National Hemophilia Foundation (NHF), Hemophilia Federation of America (HFA), and Hemophilia of Iowa (HOI) believe that they…

Continue Reading Do You Think This Is Illegal Discrimination Against Hemophilia Patients?